Please login to the form below
Sanofi Pasteur
This page shows the latest Sanofi Pasteur news and features for those working in and with pharma, biotech and healthcare.
Oncology drives AstraZeneca, Genzyme boosts Sanofi
Meanwhile, Sanofi released its Q1 results, and its growth beat expectations, driven in part by its rare disease arm Genzyme. ... The France-based drugmaker reported net sales of 8, 391m for the first quarter, an increase of 6.2%, which was also fuelled
Latest news
-
Finch’s microbiota drug for C. diff gets FDA breakthrough status
vaccines, such as Pfizer's PF-06425090 and Sanofi Pasteur's ACAM-CDIFF which are both in late-stage testing.
-
US, EU regulators back rapid reviews of AZ’s RSV med
That duration of action means it has a vaccine-like profile, which was why AZ opted to partner with Sanofi, a vaccine specialist via its Sanofi Pasteur division. ... Sanofi paid 120m upfront for a share in MEDI8897 last year with another 495m in
-
Dupixent helps put Sanofi back on growth track
Gains for vaccine division Sanofi Pasteur and the company’s specialty medicines division, which along with Dupixent includes Genzyme’s rare disease drugs and multiple sclerosis therapies like Aubagio (teriflunomide), contributed ... Meanwhile, Sanofi
-
Dupixent bounce-back helps stem diabetes declines at Sanofi
the uptick is still slow, rising from 49m in the first quarter despite Sanofi’s efforts to won over US payers, for example offering improved rebates for formulary access. ... Rare disease unit Genzyme had a good quarter, with sales up 6% to 743m, but
-
Sanofi backs vaccines unit with €350m Canadian facility
The move underlines the importance of the Sanofi Pasteur vaccines business to Sanofi even as it suffers a slowdown in growth caused in part by the label change to dengue fever ... Once completed in 2021, the new facility will also be equipped to produce
More from news
Approximately 13 fully matching, plus 132 partially matching documents found.
Latest Intelligence
-
Deal Watch March 2017
In particular the largest deal this month, between MedImmune and Sanofi Pasteur, has a headline figure of $650m, a figure which would have had the deal struggling to get into the ... Headline. $m. AstraZeneca/ MedImmune. Sanofi Pasteur. Joint Development.
-
Going fully digital
Sanofi Pasteur MSD previously required upwards of nine months to bring approved commercial content to market in many of its largest markets. ... Sanofi Pasteur MSD also projects overall efficiency gains of 17% in year one and 33% annually in years two
-
Deal Watch table for July 2014
preclinical). 225. CureVac/ Sanofi Pasteur. Exercise of option, licence. RNActive vaccine technology vs undisclosed pathogens (preclinical).
-
Pharma deals during July 2014
Scandinavia. CureVac's relationship with Sanofi Pasteur dates back to 2011 when the companies entered into a collaboration and option agreement covering mRNA-based vaccines generated using CureVac's RNActive technology ... Sanofi Pasteur has now
-
Deal Watch table for March 2014
26.6. ‡SK Chemicals/ Sanofi Pasteur. Collaboration. Pneumococcal conjugate vaccine (PCV). 23. ... Japan . Outside US, Canada. ‡ Sanofi Pasteur has rights outside Korea; SK has exclusive rights for Korea.
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Dominique Carouge joins Sanofi as head of business transformation
Carouge, who also becomes a member of Sanofi’s executive committee, will be at the helm of accelerating the transformation of the company. ... for Sanofi Pasteur since 2009.
-
STEM Healthcare bolsters its EU5 team
Meanwhile, Joanna Troman (pictured left) moves to STEM as a project director following 10 years as Sanofi Pasteur MSD in a number of roles across marketing, strategic planning and market research.
-
Hanover Brussels appoints Aurélie Marchand as account director
Prior to Hill &Knowlton, Marchand served Sanofi, where she worked on French Parliament relations and she has held several positions within the French administration working for general secretariat for European affairs ... In her new role, Marchand will
-
Cello Health Consulting expands its UK team
Tarplee has over 30 years of life science industry experience and previously worked for the likes of Adherium, ALK Abello, Sanofi and Abbott. ... Lim previously worked at Novartis and Sanofi Pasteur, and most recently served at Takeda Pharmaceuticals as
-
Dean Sowman joins Portland Health
He joins Portland from MHP Communications, where his two-year stint saw him rise to a senior account manager role and included a secondment to Sanofi Pasteur MSD’s comms team.
More from appointments
Approximately 1 fully matching, plus 16 partially matching documents found.
Latest from PMHub
-
emotive boosts health economics and outcomes research team
Sam previously held positions at Monitor and Sanofi Pasteur MSD (Merck Sharp &Dohme).
-
Happy New Year from an expanding emotive team
Adam Goodband joined emotive as a Strategic Planner in January 2014, having previously worked as a Medical Writer at Sanofi Pasteur MSD, has been promoted to Senior Strategic Planner.
-
Adam Goodband joins emotive as a Strategic Planner
emotive are pleased to announce the addition of former Sanofi Pasteur MSD medical writer to the team. ... Having experienced working alongside emotive as a medical writer for Sanofi Pasteur MSD, Adam was keen to join the team and bring his skills and
-
emotive.
emotive are pleased to announce the addition of former Sanofi Pasteur MSD medical writer to the team.
-
Publicis Resolute
Boehringer Ingelheim. GSK. Janssen. Novartis. Pfizer. Sanofi. Sanofi Pasteur MSD. Shire.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- Medical Writer/ Senior Medical Writer opportunities – Macclesfie...
-
competitive salary and benefits package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
Subscribe to our email news alerts
- Rising demand and understaffing puts NHS waiting times up again
- Lucid demonstrates continual investment in its central services with the appointment of its new Head of Talent, Resourcing and HR projects
- Bluebird puts €1.57m price on gene therapy Zynteglo
- Q&A with Raman Sehgal
- Hansoh Pharma shares head skyward after HKEX debut
- GSK joins forces with Doudna’s CRISPR lab
PMHub
Atlantis Healthcare
Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...
Latest intelligence
- What are you doing, Dave?
- Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
- Fake News is Bad for your Health
- Ill informed patients make poor health decisions...
- Secrets of Pharma Advertising
- If the goal of branding is to be different, why do so many Pharma brand ads look the same?...
Quick links
Infographics
